#LUPIN NSE: LUPIN CMP: 756 TP: 910 SL: 700 TF: <6m RR > 3 times Return > 20% THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS Factors: BULLISH WEDGE BREAKOUT Trend Following Rising...
#AUROPHARMA NSE: AUROPHARMA CMP: 437 TP: 535 SL: 400 TF: <6m RR > 3.5 times Return > 22% THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest...
#GLENMARK NSE: GLENMARK CMP: 440 TP: 515 SL: 400 TF: <6m RR > 2 times Return > 17% THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising...
#CIPLA NSE: CIPLA CMP: 1128 TP: 1250 SL: 1080 TF: <6m RR > 2.5 times Return > 11% THYROCARE CNXPHARMA LUPIN NSE: CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest...
Pfizer - 30d expiry - We look to Buy a break of 48.31 (stop at 46.56) Short term bias has turned positive. Posted a bullish Flag formation. A break of 48.26 is needed to confirm the outlook. A break of the recent high at 48.26 should result in a further move higher. Short term momentum is bullish. This stock has seen good sales growth. The bias is to break...
Pfizer (PFE) broke and closed today above the Channel Down that has been dominating the 2022 Bear Market since the January 11 High. At the same time the 1D RSI has been ranging and while the 1D MA200 (orange trend-line) held successfully last time, we do expect one last test or for an even more comfortable long-term buy, the 1D MA50 (blue trend-line). As you may...
Not financial advice. The essence of investing & trading is the intelligent and patient preying on the greed, fear, impatience, addiction and ignorance of the majority. It's definitionally Darwinian.
Pfizer is forming a head and shoulders pattern on the 2HR timeframe it has broken the right shoulder trendline and we will look to enter short and puts and play pfizer stock down to the next key levels!
Not financial advice. The essence of investing & trading is the intelligent and patient preying on the greed, fear, impatience, addiction and ignorance of the majority. It's definitionally Darwinian.
This is one of the stocks I hold indefinitely for dividends. we're at the bottom of our current channel and a double bottom is forming in a major area of support. In my previous post I stated my accumulation sections are in the lower end of the channel, so this is prime real estate to enter. Momentum downwards has come to a halt and I believe we will retest the...
pfizer is ready to see $53 , it's in G diametric pattern and it's ready to compete it to make b of flat
Pfizer Short Term - We look to Sell at 50.48 (stop at 52.47) Our outlook is bearish. Broken out of the triangle formation to the downside. This is negative for sentiment and the downtrend has potential to return. Further downside is expected although we prefer to sell into rallies close to the 51.00 level. Our profit targets will be 45.49 and 42.00...
So far this year has not been kind to stock markets. And while many drug makers have avoided a selloff, Pfizer is not one of them. The pharmaceutical giant has performed more or less on par with the broader market to date. Fortunately, Pfizer's latest quarterly report showed some very encouraging signs. However, there are also reasons to be concerned about the...
PFE is touching the diagonal trendline to the upside again. Can't wait for the breakout. LT holding with nice dividend.
Pfizer stock He is about to complete the recovery journey he started from the bottom of last June 17 Its recent decline received strong support from the $50.50 barrier And it is testing a resistance between the average 100 and 51.48 by breaching it, while reaping the momentum with a higher trading volume that increases the chances of the rise
Pfizer Short Term We look to Sell at 54.06 (stop at 56.08) Bespoke resistance is located at 54.50. A move higher faces tough resistance and we remain cautious on upside potential. Selling spikes offers good risk/reward. Further downside is expected although we prefer to sell into rallies close to the 54.60 level. We are trading at overbought extremes. Our...
Pfizer was a good long for me $$$ now at trend line resistance and as of now showing signs of weakness IMO At the least I think you can scalp a quick retracement here as an idea or reversion to the mean trade back down to the 10MA. I'm long PFE 54 Put for next week, nothing major as it's short time frame and just looking for the pullback/ rejection of this...
Nice breakout from that bullish pennant flag🔥 Monkeypox might be the next Pandemic (according to WHO) and $SIGA might be the next $MRNA (5000% up since the beginning of Covid)🚀📈